Tricida Inc
Change company Symbol lookup
Select an option...
TCDAQ Tricida Inc
HROWL HARROW HEALTH 8 625 SNR NTS
MLTX MoonLake Immunotherapeutics
TRTN Triton International Ltd
PAYA Paya Holdings Inc
MA Mastercard Inc
MWRK MetaWorks Platforms Inc
NSRGY Nestle SA
MIN MFS? Intermediate Income Fund
MCO Moody's Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Tricida, Inc. is a pharmaceutical company, which is focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101). TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal (GI), tract. Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. The Company's VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.

Closing Price
$0.0491
Day's Change
-0.0029 (-5.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0529
Day's Low
0.0427
Volume
(Light)
Volume:
5,327,152

10-day average volume:
23,112,362
5,327,152

Crown Castle Inc. Stock Falls Thursday, Underperforms Market

4:43 pm ET October 20, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Crown Castle Inc. (CCI) slid 2.98% to $126.80 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.80% to 3,665.78 and Dow Jones Industrial Average falling 0.30% to 30,333.59. This was the stock's second consecutive day of losses. Crown Castle Inc. closed $83.07 below its 52-week high ($209.87), which the company reached on December 31st.

The stock underperformed when compared to some of its competitors Thursday, as America Movil S.A.B. de C.V. Series A rose 0.06% to $16.61, SBA Communications Corp. (SBAC) fell 1.79% to $247.96, and American Tower REIT (AMT) fell 1.57% to $188.00. Trading volume (4.3 M) eclipsed its 50-day average volume of 1.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 20, 2022.

	

(END) Dow Jones Newswires

October 20, 2022 16:43 ET (20:43 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.